CEO: | Huw Jones |
CFO: | Toni Hänninen |
Independent Non-Executive Director: | Alan Barge |
Interim Chairman: | Susan (Sue) Foden |
Non-Executive Dir: |
Address: | Liverpool Science Park Innovation Centre 2, 146 Brownlow Hill, Liverpool, Merseyside, United Kingdom , L3 5RF |
Website: | http://www.evgen.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BSVYN304 |
Currency | UK Pounds |
Share Price | 0.80p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 4.05 |
52 Week Low | 0.75 |
Volume | 227,410 |
Shares Issued | 427.35m |
Market Cap | £3.42m |
RiskGrade | 304 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:24 | 84,675 @ 0.82p |
09:47 | 100,000 @ 0.82p |
08:03 | 42,735 @ 0.82p |
You are here: research